A detailed history of O'Rourke & Company, Inc transactions in Pfizer Inc stock. As of the latest transaction made, O'Rourke & Company, Inc holds 18,790 shares of PFE stock, worth $495,304. This represents 0.28% of its overall portfolio holdings.

Number of Shares
18,790
Previous 16,081 16.85%
Holding current value
$495,304
Previous $450,000 20.67%
% of portfolio
0.28%
Previous 0.25%

Shares

12 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 28, 2024

BUY
$27.7 - $31.39 $75,039 - $85,035
2,709 Added 16.85%
18,790 $543,000
Q2 2024

Jul 18, 2024

BUY
$25.26 - $29.6 $137,161 - $160,728
5,430 Added 50.98%
16,081 $450,000
Q1 2024

Apr 18, 2024

SELL
$25.89 - $29.73 $139,754 - $160,482
-5,398 Reduced 33.63%
10,651 $296,000
Q4 2023

Jan 24, 2024

SELL
$26.13 - $33.94 $131,904 - $171,329
-5,048 Reduced 23.93%
16,049 $462,000
Q3 2023

Nov 13, 2023

SELL
$32.09 - $37.51 $5,134 - $6,001
-160 Reduced 0.75%
21,097 $700,000
Q2 2023

Jul 25, 2023

BUY
$36.12 - $41.79 $15,531 - $17,969
430 Added 2.06%
21,257 $780,000
Q1 2023

May 12, 2023

SELL
$39.39 - $51.28 $21,349 - $27,793
-542 Reduced 2.54%
20,827 $850,000
Q4 2022

Feb 13, 2023

BUY
$41.75 - $54.5 $90,388 - $117,992
2,165 Added 11.27%
21,369 $1.1 Million
Q3 2022

Nov 14, 2022

BUY
$43.76 - $53.42 $24,418 - $29,808
558 Added 2.99%
19,204 $840,000
Q2 2022

Aug 12, 2022

SELL
$46.53 - $55.17 $58,115 - $68,907
-1,249 Reduced 6.28%
18,646 $978,000
Q1 2022

May 16, 2022

BUY
$45.75 - $56.69 $23,378 - $28,968
511 Added 2.64%
19,895 $1.03 Million
Q4 2021

Feb 16, 2022

BUY
$41.32 - $61.25 $800,946 - $1.19 Million
19,384 New
19,384 $1.15 Million

Others Institutions Holding PFE

About PFIZER INC


  • Ticker PFE
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 5,612,349,952
  • Market Cap $148B
  • Description
  • Pfizer Inc. discovers, develops, manufactures, markets, distributes, and sells biopharmaceutical products worldwide. It offers medicines and vaccines in various therapeutic areas, including cardiovascular metabolic and women's health under the Premarin family and Eliquis brands; biologics, small molecules, immunotherapies, and biosimilars under ...
More about PFE
Track This Portfolio

Track O'Rourke & Company, Inc Portfolio

Follow O'Rourke & Company, Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of O'Rourke & Company, Inc, based on Form 13F filings with the SEC.

News

Stay updated on O'Rourke & Company, Inc with notifications on news.